Carregant...
Treatment strategies in axial spondyloarthritis: what, when and how?
There have been major advances in the management of axial spondyloarthritis (axSpA) with the introduction of effective biologic agents targeting TNF and IL-17A. Clinicians now have more choice but, despite treatment recommendations, are still faced with significant uncertainty when deciding on the o...
Guardat en:
| Publicat a: | Rheumatology (Oxford) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7566463/ https://ncbi.nlm.nih.gov/pubmed/33053192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa435 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|